Stock market news

Buryatzoloto

Buryatzoloto's RAS net profit for 3 months of 2024 amounted to ₽364.3 million, up 6.3% from ₽342.6 million in the previous year.

Mobile TeleSystems

Shareholders of Mobile TeleSystems approved dividends for 2023 in the amount of ₽35 per ordinary share. The last day of purchase of securities to receive dividends is July 15, 2024. Dividend yield may amount to 11.97%.

Tatneft

Tatneft shareholders approved dividends for 2023 in the amount of ₽25.17 per ordinary and preferred share. The last day to purchase securities to receive dividends is July 8, 2024. The dividend yield on the common stock could be 3.57%, while the preferred stock could yield 3.68%.

Bashinformsvyaz

Board of Directors of Bashinformsvyaz recommended to pay dividends of ₽0.67 per preferred share for 2023. The last day to purchase securities for dividends is July 11, 2024. The dividend yield could be 5.27%. No dividends to be paid on common shares.

Rosseti Moscow Region

Shareholders of Rosseti Moscow Region approved dividends for 2023 in the amount of ₽0.14282 per ordinary share. The last day of purchase of securities to receive dividends is July 4, 2024. Dividend yield may amount to 10.7%.

Softline

Softline intends to make a number of large M&A deals to acquire high-tech companies within the framework of the Company's development strategy, which implies, among other things, active consolidation of the Russian IT market. To finance the M&A-strategy, the company will place another 76 million shares by public subscription. Price of the placement will be d...

NOVATEK

Novatek plans to ship the 2nd liquefaction line for Arctic LNG-2 from Murmansk in late July, sources told Reuters. Plans show that Novatek is pursuing the delayed project despite Western sanctions that have limited access to technology and the availability of liquefied natural gas tankers, the publication said.

Artgen

Nextgen Biotech plans to launch a program of inbound medical tourism to Russia for patients from the People's Republic of China. Company will offer Chinese citizens treatment of chronic lower limb ischemia with the drug Neovasculgen developed by the company. After the completion of clinical trials of the drug for other indications, domestic and foreign patie...

Diasoft

Diasoft's IFRS net profit for 2023 amounted to ₽3.06 billion, up 16.3% from ₽2.63 billion in the previous year. Revenue rose 27.2% to ₽9.14 billion compared to ₽7.188 billion a year earlier.

Mosenergo

Shareholders of Mosenergo approved dividends for 2023 in the amount of ₽0.16038 per ordinary share. The last day of purchase of securities to receive dividends is July 8, 2024. Dividend yield may amount to 5.06%.